Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Erik Pong"'
Autor:
Jing Qi, Tian Zhang, Ke Liu, Christine Bonzon, Rumana Rashid, Rena Bahjat, Erik Pong, Elizabeth Henderson, Katrina Bykova, Kendra N Avery, John R Desjarlais, Matthew S Faber, Nahee Kim, Matthew J Bernett, James Wieler, Juan E Diaz, William Y Yeh, Su-Shin Hao
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/c83ad8214d8541a1ad85471d64afbb80
Autor:
Seung Y. Chu, Erik Pong, Christine Bonzon, Ning Yu, Chaim O. Jacob, Samantha A. Chalmers, Chaim Putterman, David E. Szymkowski, William Stohl
Publikováno v:
Journal of Translational Autoimmunity, Vol 4, Iss , Pp 100075- (2021)
Engagement of Fcγ receptor IIb (FcγRIIb) suppresses B cell activation and represents a promising target for therapy in autoimmunity. Obexelimab is a non-depleting anti-human CD19 mAb with an Fc region engineered to have high affinity for human Fcγ
Externí odkaz:
https://doaj.org/article/91722979a7e84632bcf95a6a9239fd8d
Autor:
Gregory Moore, Lukasz Ochyl, Christine Bonzon, Seung Chu, Rumana Rashid, John Desjarlais, Kendra Avery, Suzanne Schubbert, Erik Pong, Alex Nisthal, James Ernst
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/57dc984eb5824ed799cca2f897161d6b
Autor:
Eugene A. Zhukovsky, John R. Desjarlais, Roland Repp, Patrick F. Joyce, Igor Vostiar, John O. Richards, Seung Y. Chu, Sher Karki, Matthias Peipp, Erik Pong, Matthew J. Bernett, Holly M. Horton
Supplementary Figure 1 from Potent In vitro and In vivo Activity of an Fc-Engineered Anti-CD19 Monoclonal Antibody against Lymphoma and Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2413da5ba7c94cdaf17aec8c62e5aace
https://doi.org/10.1158/0008-5472.22375889
https://doi.org/10.1158/0008-5472.22375889
Autor:
Eugene A. Zhukovsky, John R. Desjarlais, Roland Repp, Patrick F. Joyce, Igor Vostiar, John O. Richards, Seung Y. Chu, Sher Karki, Matthias Peipp, Erik Pong, Matthew J. Bernett, Holly M. Horton
Supplementary Figure 2 from Potent In vitro and In vivo Activity of an Fc-Engineered Anti-CD19 Monoclonal Antibody against Lymphoma and Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11125e1a698038f30d8ba2f8c030c832
https://doi.org/10.1158/0008-5472.22375886.v1
https://doi.org/10.1158/0008-5472.22375886.v1
Autor:
Eugene A. Zhukovsky, John R. Desjarlais, Roland Repp, Patrick F. Joyce, Igor Vostiar, John O. Richards, Seung Y. Chu, Sher Karki, Matthias Peipp, Erik Pong, Matthew J. Bernett, Holly M. Horton
Supplementary Figure Legends 1-3 from Potent In vitro and In vivo Activity of an Fc-Engineered Anti-CD19 Monoclonal Antibody against Lymphoma and Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c922c9b540c134dfce296948c2e7cc7
https://doi.org/10.1158/0008-5472.22375880
https://doi.org/10.1158/0008-5472.22375880
Autor:
Tian Zhang, Matthew Faber, Erik Pong, Ke Liu, Matthew Bernett, Christine Bonzon, Juan Diaz, Dong Hyun Nam, Kendra Avery, Jing Qi, Rumana Rashid, Rena Bahjat, John Desjarlais, Katrina Bykova
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::678923e37366cf3ce4aee3c974186428
https://doi.org/10.1136/jitc-2022-sitc2022.1067
https://doi.org/10.1136/jitc-2022-sitc2022.1067
Autor:
Seung Y, Chu, Erik, Pong, Christine, Bonzon, Ning, Yu, Chaim O, Jacob, Samantha A, Chalmers, Chaim, Putterman, David E, Szymkowski, William, Stohl
Publikováno v:
Journal of Translational Autoimmunity
Engagement of Fcγ receptor IIb (FcγRIIb) suppresses B cell activation and represents a promising target for therapy in autoimmunity. Obexelimab is a non-depleting anti-human CD19 mAb with an Fc region engineered to have high affinity for human Fcγ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7ef4e64a84708c78741f10b1ba46b4f4
https://pubmed.ncbi.nlm.nih.gov/33409482
https://pubmed.ncbi.nlm.nih.gov/33409482
Autor:
John M. Robinson, Latha P. Ganesan, Dhruvi Joshi, Menakshi Bhat, Stephanie Seveau, Lars Hangartner, Qian Wu, Thushara A. Thomas, Erik Pong, Murugesan V. S. Rajaram, James M. Turman, David E. Szymkowski, Jesse J. Kwiek, Amit Sharma, Seung Y. Chu, Charu Tiwari, Dennis R. Burton, Alana M. Cheplowitz, Jonghan Kim
Publikováno v:
J Immunol
Neutralizing Abs suppress HIV infection by accelerating viral clearance from blood circulation in addition to neutralization. The elimination mechanism is largely unknown. We determined that human liver sinusoidal endothelial cells (LSEC) express Fc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d03591f8b3025d509ce37cf650f35e2c
https://pubmed.ncbi.nlm.nih.gov/33568400
https://pubmed.ncbi.nlm.nih.gov/33568400
Autor:
Sheryl Phung, John R. Desjarlais, Irene Leung, Sung-Hyung Lee, Karen C. Yeter, Erik Pong, Roshan Kotha, David E. Szymkowski, Seung Y. Chu, Christine Bonzon, William Stohl, Yvonne Miranda, Hsing Chen
Publikováno v:
Arthritis & Rheumatology. 66:1153-1164
Objective Engagement of Fcγ receptor IIb (FcγRIIb) suppresses B cell activation and represents a promising target for therapy in autoimmunity. The aim of this study was to characterize B cell immunosuppression mediated by the Fc-engineered antibody
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f83a990981fdf460a9535348a891fc2
https://doi.org/10.1002/art.38334
https://doi.org/10.1002/art.38334